184 citations to 10.1086/340402 (Crossref Cited-By Service)
  1. Chiara Cattaneo, Francesca Antoniazzi, Mario Tumbarello, Cristina Skert, Erika Borlenghi, Francesca Schieppati, Elisa Cerqui, Chiara Pagani, Marta Petullà, Alessandro Re, Giuseppe Rossi, “Relapsing bloodstream infections during treatment of acute leukemia”, Ann Hematol, 93, no. 5, 2014, 785  crossref
  2. Arne Simon, “Chemoprophylaxe bakterieller Infektionskrankheiten in der pädiatrischen Onkologie: Diskussion einer aktuellen Literaturrecherche”, Krankenhaus-Hygiene + Infektionsverhütung, 29, no. 2, 2007, 50  crossref
  3. Lionel K.K. Tan, Sandra Lacey, Sundhiya Mandalia, Mark Melzer, “Hospital-based study of viridans streptococcal bacteraemia in children and adults”, Journal of Infection, 56, no. 2, 2008, 103  crossref
  4. Dong Hoe Koo, Ock Bae Ko, Shin Kim, Dae Ho Lee, Sang We Kim, Cheolwon Suh, “Prospective Randomized Comparative Observations of Infectious Complications with or without Antimicrobial Prophylaxis, during Autologous Stem Cell Transplantation”, Korean J Hematol, 41, no. 4, 2006, 282  crossref
  5. Sarah P. Hammond, Lindsey R. Baden, “Antibiotic prophylaxis during chemotherapy-induced neutropenia for patients with acute leukemia”, Curr Hematol Malig Rep, 2, no. 2, 2007, 97  crossref
  6. Todd Kitten, Cindy L. Munro, Nicai Q. Zollar, Sehmi P. Lee, Resham D. Patel, “Oral Streptococcal Bacteremia in Hospitalized Patients: Taxonomic Identification and Clinical Characterization”, J Clin Microbiol, 50, no. 3, 2012, 1039  crossref
  7. Dana Jaffe, Ann Jakubowski, Kent Sepkowitz, R. Sebti, Timothy E. Kiehn, Eric Pamer, Genovefa A. Papanicolaou, “Prevention of Peritransplantation Viridans Streptococcal Bacteremia with Early Vancomycin Administration: A Single‐Center Observational Cohort Study”, CLIN INFECT DIS, 39, no. 11, 2004, 1625  crossref
  8. Shinnosuke Fukushima, Hideharu Hagiya, Yuki Mizuta, Yasuhiro Nakano, Masahiro Takahara, Kayo Okamoto, Yuko Hayashi, Kiyoshi Yamada, Kou Hasegawa, Fumio Otsuka, “Multiple Deep-seated Dentofacial Abscesses Caused by Multidrug-resistant Viridans Group Streptococci”, Intern. Med., 59, no. 16, 2020, 2067  crossref
  9. T. G. Fraser, S. M. Gordon, “CLABSI Rates in Immunocompromised Patients: A Valuable Patient Centered Outcome?”, Clinical Infectious Diseases, 52, no. 12, 2011, 1446  crossref
  10. Vicki A. Morrison, “An Overview of the Management of Infection and Febrile Neutropenia in Patients with Cancer”, Supportive Cancer Therapy, 2, no. 2, 2005, 88  crossref
1
2
3
4
19
Next